Outcome After Plate Osteosynthesis of Proximal Humerus Fractures Using Continous Passive Motioning Therapy

July 17, 2023 updated by: Technische Universität Dresden

Comparison of Functional and Patient-reported Outcome Using Continuous Passive Motion in Rehabilitation After Plate Osteosynthesis of Proximal Humerus Fractures

Patients suffering from a proximal humerus fracture treated with plate osteosynthesis will receive either regular aftercare (physiotherapy) or aftercare assisted with continous passive motion (physiotherapy + CPM). Change in functional and patient-reported outcome (PROM) over time will be evaluated and compared.

Study Overview

Status

Active, not recruiting

Detailed Description

The investigators will conduct a prospective, monocentric study focusing on the rehabilitation process after surgical treatment of proximal humerus fractures. Patients treated with plate osteosynthesis and eligible to participate will be randomly assigend to either a regular rehabilitation protocol (immobilization and physiotherapy) or a rehabilitation protocol with the additional use of a continous passive motion device (immobilization, physiotherapy and CPM).

After 6 and 12 weeks as well as 1 year in a follow-up examination functional (range of motion) and patient-reported outcome (Disabilities of Arm, Shoulder and Hand Score [DASH], Constant-Score, pain on visual analogue scale, subjective satisfaction) will be evaluated. Results will be compared towards possible differences and effect of CPM therapy. In addition demographic factors (age, sex, BMI, etc.) and complications will be analysed.

Study Type

Interventional

Enrollment (Actual)

103

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Saxonia
      • Dresden, Saxonia, Germany, 01307
        • University Center of Orthopaedics and Traumatology, University Medicine Carl Gustav Carus Dresden, TU Dresden

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients with proximal humeral fracture treated with plate osteosynthesis during the enrollment period
  • understanding of German language (written and oral)
  • written informed consent of the patient or the legal guardian

Exclusion Criteria:

  • patients not meeting the aforementioned criteria
  • patients with the need of / or an already existing endoprosthesis
  • patients with ipsilateral fracture of the distal radius
  • patients with cerebral damage (contusio or commotio cerebri)
  • patients with affection of the brachial plexus or nerve palsy
  • non-compliance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard rehabilitation protocol
Standard rehabilitation after surgical treatment consisting of initial immobilization followed by physiotherapy.
Active Comparator: Rehabilitation protocol with CPM
Additional treatment of patients with continuous passive motion after initial immobilization for 6 weeks.
Patients will be supplied with a continuous passive motion device which will allow additional individual treatment of the affected shoulder for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Range of Motion (ROM) after 6 weeks, 12 weeks and 1 year
Time Frame: Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Objetive functional clinical result. Evaluation ot Motion of the shoulder in ° measured via goniometer. Physiological Abduction/Adduction: 180/0/40°, Anteversion/Retroversion 160/0/40°, external/internal rotation: 70/0/60°
Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Change of Disabilities of Arm, Shoulder and Hand Score (DASH) after 6 weeks, 12 weeks and 1 year
Time Frame: Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Evaluation of the subjective function (patient reported outcome) using the DASH-Score, 0-100, best: 0, worst: 100
Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Change of Constant-Score (CSS) after 6 weeks, 12 weeks and 1 year
Time Frame: Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Evaluation of the subjective function (patient reported outcome) using the Constant-Score, 0-100, best: 100, worst: 0
Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Change of Pain on visual analogue scale (VAS) after 6 weeks, 12 weeks and 1 year
Time Frame: Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Evaluation of the subjective pain using a visual analogue scale, 0-10, best:0, worst: 10
Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Change of Subjective satisfaction with surgical treatment (SSV) after 6 weeks, 12 weeks and 1 year
Time Frame: Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Evaluation of the subjective satisfaction using the subjective shoulder value, 0-100, best:100, worst: 0
Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Influence of demographic factors upon rehabilitation process
Time Frame: Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment
Evaluation of the underlying demographic factors (gender, age, BMI) and whether these affect the functional and patient-reported outcome (univariate regressional analysis)
Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2018

Primary Completion (Actual)

February 28, 2022

Study Completion (Estimated)

December 31, 2023

Study Registration Dates

First Submitted

April 19, 2023

First Submitted That Met QC Criteria

July 17, 2023

First Posted (Actual)

July 19, 2023

Study Record Updates

Last Update Posted (Actual)

July 19, 2023

Last Update Submitted That Met QC Criteria

July 17, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Proximal Humerus Fracture

Clinical Trials on Continuous passive motion therapy

3
Subscribe